Veradermics, Inc.
Clinical trials sponsored by Veradermics, Inc., explained in plain language.
-
New pill for baldness shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental oral drug called VDPHL01 for people with mild to moderate pattern baldness (androgenetic alopecia). About 70 men and women aged 18-65 will take the drug daily for 12 months. Researchers will measure changes in hair count and ask participants how t…
Phase: PHASE2 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
New pill could help men regrow hair
Disease control OngoingThis study tests an experimental oral drug called VDPHL01 for male pattern baldness (androgenetic alopecia). About 480 men aged 18 to 65 with mild to moderate hair loss will take either the drug or a placebo for 6 months, then all will receive the active drug for another 6 months…
Phase: PHASE2, PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC